85 related articles for article (PubMed ID: 8713440)
1. [Effect of fluoroquinolones on the interaction of phagocytic cells with pathogens, lymphocyte function and immune response].
Iordanova AI; Smolkina TV; Nikitin AV
Antibiot Khimioter; 1995 Aug; 40(8):50-6. PubMed ID: 8713440
[No Abstract] [Full Text] [Related]
2. [Effect of contemporary chemotherapeutic drugs on phagocyte activity and the immune response].
Nikitin AV; Navashin PS; Smolkina TV
Antibiot Khimioter; 1996; 41(7-8):49-56. PubMed ID: 8999764
[No Abstract] [Full Text] [Related]
3. [Penetration and intracellular activity of fluoroquinolones].
Pascual A; García I
Enferm Infecc Microbiol Clin; 1998 Mar; 16(3):138-43. PubMed ID: 9611878
[No Abstract] [Full Text] [Related]
4. The effect of antibiotics on the function of the phagocytic system.
Miler I; Borte M; Hejzlar M; Braun W
Padiatr Grenzgeb; 1990; 29(5):377-85. PubMed ID: 2234979
[TBL] [Abstract][Full Text] [Related]
5. [Effect of five fluoroquinolones on the bactericidal activity of human polymorphonuclear leukocytes against Staphylococcus aureus].
Ballesta S; Pascual A; García I; Conejo C; Perea EJ
Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):600-3. PubMed ID: 9053002
[TBL] [Abstract][Full Text] [Related]
6. Modulation of phagocytosis and bactericidal activity of human polymorphonuclear and mononuclear phagocytes by antiarthritic agents.
Pruzanski W; Saito S; DeBoer G
J Rheumatol; 1983 Apr; 10(2):197-203. PubMed ID: 6864673
[TBL] [Abstract][Full Text] [Related]
7. Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells.
Uriarte SM; Molestina RE; Miller RD; Bernabo J; Farinati A; Eiguchi K; Ramirez JA; Summersgill JT
Antimicrob Agents Chemother; 2004 Jul; 48(7):2538-43. PubMed ID: 15215106
[TBL] [Abstract][Full Text] [Related]
8. Rufloxacin enhances susceptibility of Escherichia coli to leukocyte activity.
Herrera I; Martinez P; Perez P; Martin M; Gomez-Lus ML; Prieto J
J Chemother; 1995 Nov; 7 Suppl 4():36-7. PubMed ID: 8904099
[No Abstract] [Full Text] [Related]
9. [Effect of lomefloxacin on the functional activity of the phagocytic system].
Mozhokina GN; Gracheva MP; Sokolova GB
Antibiot Khimioter; 1996 Mar; 41(3):25-8. PubMed ID: 8967798
[TBL] [Abstract][Full Text] [Related]
10. [Other communal respiratory pathogens and new fluoroquinolones].
Cantón R; Loza E; Valdezate S; Baquero F
Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():12-21; discussion 47-52. PubMed ID: 10344094
[No Abstract] [Full Text] [Related]
11. Hydrophobic sodium fluoride-based nanocrystals doped with lanthanide ions: assessment of in vitro toxicity to human blood lymphocytes and phagocytes.
Sojka B; Kuricova M; Liskova A; Bartusova M; Banski M; Misiewicz J; Dusinska M; Horvathova M; Jahnova E; Ilavska S; Szabova M; Rollerova E; Podhorodecki A; Tulinska J
J Appl Toxicol; 2014 Nov; 34(11):1220-5. PubMed ID: 25179008
[TBL] [Abstract][Full Text] [Related]
12. [Effects of polysaccharide of Polygala aureocauda on the immunnity functions of normal mouse].
Qin H; Xia X; Li Z
Zhong Yao Cai; 1998 Sep; 21(9):467-9. PubMed ID: 12569840
[TBL] [Abstract][Full Text] [Related]
13. New classification and update on the quinolone antibiotics.
King DE; Malone R; Lilley SH
Am Fam Physician; 2000 May; 61(9):2741-8. PubMed ID: 10821154
[TBL] [Abstract][Full Text] [Related]
14. The interferons, macrophage activation, and host defense against nonviral pathogens.
Murray HW
J Interferon Res; 1992 Oct; 12(5):319-22. PubMed ID: 1385553
[No Abstract] [Full Text] [Related]
15. Lymphocyte nucleoli activation and changes of the mononuclear phagocytic system in mice during 3-methylcholanthrene carcinogenesis.
Kofránek V; Koprivová H
Cytobios; 1983; 38(150):97-105. PubMed ID: 6641283
[TBL] [Abstract][Full Text] [Related]
16. [Suppressor effect induced by sodium periodate on the antibody response of mouse splenic cells in vitro : inhibition of this effect by sodium borohydride].
Danois D; Banchereau J; Guénounou M; Agneray J
C R Seances Acad Sci D; 1979 Jun; 288(21):1631-3. PubMed ID: 226283
[TBL] [Abstract][Full Text] [Related]
17. Use of fluoroquinolones: practical considerations.
Ponte CD; Fisher MA
Am Fam Physician; 1993 Apr; 47(5):1243-9. PubMed ID: 8465719
[TBL] [Abstract][Full Text] [Related]
18. [Interaction between anti-infective agents and phagocytes].
Labro MT
Presse Med; 1995 Jun; 24(21):992-8. PubMed ID: 7667224
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolones: a new treatment for tuberculosis?
Gillespie SH; Kennedy N
Int J Tuberc Lung Dis; 1998 Apr; 2(4):265-71. PubMed ID: 9559396
[TBL] [Abstract][Full Text] [Related]
20. Highlights on the appropriate use of fluoroquinolones in respiratory tract infections.
Blasi F; Tarsia P; Aliberti S; Santus P; Allegra L
Pulm Pharmacol Ther; 2006; 19 Suppl 1():11-9. PubMed ID: 16310389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
